Sigachi Laboratories Limited Unlisted Share Price
Sigachi Laboratories Limited unlisted share price is ₹52 per share (indicative, as of 17 Oct 2026). Minimum ticket ₹25,000 (lot of 485 shares), the same for every company. Sector: Consumer. Status: unlisted, no DRHP on record.
All unlisted share prices: dated indicative prices for every company the desk tracks.
Updated 17 Oct 2026, 22:10 IST. Dated dealer references.
BuyUnlistedShares tracks 230 unlisted companies with dated prices; Sigachi Laboratories Limited’s indicative price is ₹52 per share as of 17 Oct 2026, a lot of 485 shares.
Key facts
- Indicative price
- ₹52 per share
- Price as of
- 17 Oct 2026
- Minimum investment
- ₹25,000
- Lot size
- 485 shares
- Sector
- Consumer
- Listing status
- Unlisted
- Settlement
- Demat to demat; terms agreed in writing for each deal
- Last updated
- 17 Oct 2026, 22:10 IST
Indicative and dated. BuyUnlistedShares deals as principal.
Buying at a glance
- Minimum ticket
- ₹25,000
- Price shown
- Indicative, dated 17 Oct 2026
- Delivery
- Shares are credited to your demat account
In plain words
- Lock-in if it lists
- Shares bought before an IPO are generally locked in for six months from the IPO allotment date under SEBI rules. The issue documents set the exact terms.
- Demat
- Yes. ISIN INE368H01018: the shares sit in your own demat account and move demat to demat through NSDL or CDSL.
- IPO status
- Unlisted. No DRHP on record.
Facts only, not a rating or a recommendation.
Compare it against the full unlisted share price list: every company the desk quotes, each with a dated indicative price.
Indicative quote unchanged since 12 Sep 2025 (778 dated quotes); no price movement to chart yet.
Key figures
| Market cap | ₹35.12 Cr |
|---|---|
| Minimum investment | ₹25,000 |
| Lot size | 485 |
| P/E ratio | 28.42x |
| ROE | 3.03% |
| Book value | ₹58.39 |
| Face value | ₹10 |
| 52-week high | ₹52 |
| 52-week low | ₹52 |
| ISIN | INE368H01018 |
| Dividend yield | — |
Financials (₹ Cr)
| Metric | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue | 1.95 | 3.74 | 3.12 |
| PAT | 1.31 | 1.97 | 1.19 |
| EPS (₹) | 1.79 | 2.69 | 1.63 |
About the company
Sigachi Laboratories Limited is a Telangana-based pharmaceutical manufacturer incorporated in 1994, operating in the bulk drugs and drug intermediates space. The company produces active pharmaceutical ingredients and intermediate chemical compounds that serve as the building blocks for finished formulations, supplying these inputs to the broader pharmaceutical and chemical manufacturing chain.
Prices shown are indicative and dated. Unlisted shares are illiquid and values can move sharply.
Registered in Hyderabad, Telangana.
Registry
- ISIN: INE368H01018
- Depository: NSDL & CDSL
- Listed at: Unlisted
- Price as of: 17 Oct 2026
Company facts
| CIN | L24230TG1994PLC018786 |
|---|---|
| Incorporated | 1994 |
| ISIN | INE368H01018 |
| Face value | ₹10 |
| Registered office | S. No. 530 & 534, Bonthapally – 502313, Jinnaram Mandal, Telangana, India |
| Shares outstanding | 67,53,100 |
| Lot size | 485 shares |
| Minimum units | 195 |
| DRHP | Not filed |
Financial statements (₹ Cr)
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 vs FY25 |
|---|---|---|---|---|---|---|
| Revenue | 2.6 | 1.95 | 3.74 | 3.12 | 3.26 | +4.5% |
| EBITDA | — | 1.42 | 2.42 | 1.09 | 1.32 | +21.1% |
| Profit before tax | — | 1.73 | 2.81 | 1.52 | 1.81 | +19.1% |
| Profit after tax | 2 | 1.31 | 1.97 | 1.19 | 1.34 | +12.6% |
| EPS (₹) | 2.74 | 1.79 | 2.69 | 1.63 | 1.83 | +12.3% |
| Operating margin | 81.2% | 72.8% | 64.7% | 34.9% | — | — |
| Net margin | 76.9% | 67.2% | 52.7% | 38.1% | — | — |
| Share capital | 7.31 | 7.31 | 7.31 | 7.31 | — | — |
| Reserves & surplus | 22.44 | 23.43 | 28.7 | 32.02 | — | — |
| Net worth | 29.75 | 30.74 | 36.01 | 39.33 | — | — |
| Fixed assets | 2.29 | 2.37 | 3.21 | 3.1 | — | — |
| Investments | 21.51 | 19.66 | 26.63 | 29.78 | — | — |
| Trade receivables | 0.16 | 0.01 | 0.2 | 0.03 | — | — |
Key ratios and valuation
| Measure | Value | Basis |
|---|---|---|
| Indicative price | ₹52 | dealer reference, 17 Oct 2026 |
| Market cap | ₹35.12 Cr | price × 67,53,100 shares |
| P/E | 28.42x | price ÷ EPS ₹1.83 (FY26) |
| P/B | 0.89x | price ÷ book value ₹58.39 |
| EPS | ₹1.83 | per share, FY26 |
| Book value | ₹58.39 | per share, latest books |
| RoE | 3.03% | return on equity, latest FY |
| Debt / equity | 0 | latest balance sheet |
| Dividend yield | — | |
| Face value | ₹10 | per share |
| 52-week range | ₹52 (unchanged) | quote unchanged since 17 Oct 2025 |
| Shares outstanding | 67,53,100 | per company record |
Management and promoters
| Name | Designation | Experience |
|---|---|---|
| T. Adinarayana | Chairman | — |
| T.R. Sekhar | Executive Director | — |
| B. Kumar | CFO | — |
| China Sai Babu Puppala | Director | — |
| Rajasekhar Tunuguntla | Whole-time Director | — |
| Shilpa Bung | Director | — |
Business model
Sigachi Laboratories Limited is a listed company whose 2024-25 annual report describes it as engaged in manufacturing bulk drugs or drug intermediates. Its registered office and Unit I are at Bonthapally, Telangana; the report identifies a second factory at Ali Nagar. The issuer’s financial statements record revenue from operations and other income, and the directors’ report states that the company leased its two factories from 1 May 2025 for 15 years after receiving approvals.
The report also states that the company provides demand loans or inter-corporate deposits to parties and receives interest, with no overdue loans or inter-corporate deposits reported by management. The company’s securities are listed on the Metropolitan Stock Exchange of India Limited. The audited financial statements use Ind AS and were approved by the board on 29 May 2025. This is a factual description of the business configuration stated in the latest annual report; it does not characterize current operational scale or make a forecast.
Corporate actions and events
| Date | Type | Detail | Ratio / amount | Source |
|---|---|---|---|---|
| Undated | Other | The Nomination and Remuneration Committee and Board considered and recommended Dr. Govindarajula Venkata Narasimha Rao's appointment as an Independent Director, subject to shareholder approval. (14 Aug 2025) | — | Desk note |
Reports and filings
No filings uploaded yet.
Annual reports
- Sigachi Laboratories Limited annual report 2024-25 (PDF)
- Sigachi Laboratories Limited annual report 2023-24 (PDF)
- Sigachi Laboratories Limited annual report 2022-23 (PDF)
- Sigachi Laboratories Limited annual report 2021-22 (PDF)
Frequently asked questions
What does Sigachi Laboratories Limited do?
Sigachi Laboratories Limited is a Telangana-based pharmaceutical company incorporated in 1994. It manufactures bulk drugs and drug intermediates (active pharmaceutical ingredients and related chemical compounds) used as inputs in finished pharmaceutical formulations, with manufacturing facilities in the Bonthapally area of Sangareddy district.
Is Sigachi Laboratories Limited listed on the NSE or BSE, and how are its unlisted shares bought?
Sigachi Laboratories Limited is not listed or actively traded on the NSE or BSE main board; it is admitted on the Metropolitan Stock Exchange of India (MSEI), a regional exchange with limited trading. It should not be confused with the separately listed Sigachi Industries Limited. Its shares are generally transacted in the over-the-counter unlisted market through off-market transfers between a buyer and seller, settled into a demat account via NSDL or CDSL.
What determines the indicative price of Sigachi Laboratories Limited unlisted shares?
Because the shares are not actively traded on a major exchange, the indicative price reflects negotiated dealing in the private unlisted market rather than continuous exchange-based price discovery. Factors that participants typically consider include the company's reported financials such as book value and earnings per share, sector conditions in the bulk-drug space, share availability and demand, and overall sentiment. The indicative figure is market data only and can vary between sources and over time.
What are the key fundamentals of Sigachi Laboratories Limited?
Key identifiers include CIN L24230TG1994PLC018786 and ISIN INE368H01018, with a face value of ₹10 per share and incorporation in 1994. The company has a relatively small equity base of roughly 6.75 million shares and is registered in Telangana. Its income is derived mainly from pharmaceutical products (bulk drugs and drug intermediates) along with interest income. These details are factual and provided for information only.
What is the Sigachi Laboratories Limited unlisted share price today?
The indicative over-the-counter reference price is ₹52 per share as of 17 Oct 2026. It is a dated dealer reference, refreshed every working day.
Is Sigachi Laboratories Limited listed on a stock exchange?
Not yet. Sigachi Laboratories Limited changes hands in the unlisted market, over the counter and settle into your demat account through NSDL and CDSL.
What is the minimum investment in Sigachi Laboratories Limited?
The minimum ticket is ₹25,000, the same for every company on the site.
What is the ISIN of Sigachi Laboratories Limited?
INE368H01018. Holdings are settled in demat form through NSDL and CDSL.
How do I buy Sigachi Laboratories Limited unlisted shares?
Send an enquiry with the quantity you have in mind. The desk replies with a dated quote, the paperwork list and the demat steps, and the shares settle demat to demat into your own account.
Is there a lock-in if Sigachi Laboratories Limited lists?
Pre-IPO shareholders other than promoters are generally locked in for six months from the date of IPO allotment under SEBI ICDR regulation 17. The final offer document sets the exact terms.
Sources
- Sigachi Laboratories Limited annual report 2024-25 · FY 2024-25 · slllab.com
- Sigachi Laboratories Limited annual report 2023-24 · FY 2023-24 · slllab.com
- Sigachi Laboratories Limited annual report 2022-23 · FY 2022-23 · slllab.com
- Sigachi Laboratories Limited annual report 2021-22 · FY 2021-22 · slllab.com
- BuyUnlistedShares indicative price series for Sigachi Laboratories Limited, dated daily · since 12 Sep 2025 (343 dated quotes) · buyunlistedshares.com
How to cite this page: BuyUnlistedShares, “Sigachi Laboratories Limited unlisted share price”, https://buyunlistedshares.com/unlisted-shares/sigachi-laboratories-limited, as of 17 Oct 2026.
Other Consumer unlisted shares
- A V Thomas & Co. Limited · ₹12,500
- Anglo French Drugs and Industries · ₹1,075
- Anheuser Busch Inbev India (AB InBev) · ₹555
- Apollo Fashion International · ₹44
- Arch Pharmalabs Limited · ₹85
- Auckland Jute Co. Limited · ₹189
Enquire to buy Sigachi Laboratories Limited · Sell a holding
Indicative reference price, dated. BuyUnlistedShares is India's premium unlisted shares desk, run by Gayatri Financial Synergy LLP. In the market since 2002. Data as of 17 Oct 2026.
Before you buy: guides
- How to evaluate an unlisted company before investing
- How Unlisted Share Prices Are Discovered When There Is No Live Order Book
- The risks of buying unlisted and pre-IPO shares in India
- Unlisted Shares Lock-In Period: What Every Investor Must Know (2026)
- Can an NRI invest in unlisted shares in India?
All unlisted shares · IPO calendar · Research & learning · Send an enquiry · Calculators · Jobs · About · Contact · Privacy · Terms · Disclaimer · Grievance redressal
Guides: Start investing · Evaluate a company · How prices are set · Risks · Lock-in periods · After the IPO · Sell ESOPs · NRI investors · Buybacks · Choosing a platform
BuyUnlistedShares (BUS) · Gayatri Financial Synergy LLP (LLPIN ACU-4678) · SCO-39, 1st Floor, HUDA Market, Sector-7, Faridabad, Haryana 121006 · +91 916-916-59-59
